Colgate-Palmolive (CL) Upgraded to Outperform, Target Price Rais

RBC Capital Markets has upgraded Colgate-Palmolive (CL) to "Outperform" and raised its target price by 18% to $88, citing the company's consistent organic sales growth and effective management strategies despite global economic challenges. The report highlights Colgate-Palmolive's strong market position in household and personal care, robust international sales, and ownership of Hill's pet food. While noting a declining operating margin and high debt-to-equity ratio as warning signs, the analysis suggests a stable outlook with potential for growth, supported by a strong Altman Z-Score and positive analyst sentiment.